Studies in mice suggest that the elastin microfibril interfacer-1 gene (EMILIN1), the gene encoding elastin microfibril interfacer-1 protein, contributes to the pathogenesis of essential hypertension (EH) in humans. EMILIN1 in part maintains elastic fibres in vessel walls, and hence peripheral arterial compliance. In a casecontrol study, we assessed 942 non-obese non-diabetic Chinese, comprising 467 patients with EH and 475 normotensive control subjects (166 without, and 309 with, family history of hypertension in first-degree relatives (FHH)). Hypertension in first-degree relatives occurred in 88%, 65% and 0% of cases, all controls and controls without FHH, respectively. We scanned for single-nucleotide polymorphisms (SNPs) and genotyped them in the EMILIN1 gene using high-resolution melt-curve analysis. No exonic variants were detected. We assessed the association of SNPs and their haplotypes with EH. Three SNPs in introns 1 and 5 (rs2289360, rs2011616 and rs7424556) were in strong pair-wise linkage disequilibrium (r 2 40.89). All three SNPs were significantly associated with hypertension. Genotypic frequencies at the three SNPs differed significantly between cases and only those controls without FHH. Healthy controls with FHH should be excluded to increase the odds of detecting association. All the G alleles of rs2289360 (odds ratio ¼ 1.69, P ¼ 0.010), rs2011616 (odds ratio ¼ 1.52, P ¼ 0.038) and rs7424556 (odds ratio ¼ 1.59, P ¼ 0.023) were high-risk alleles in the recessive genetic model. We observed significant overall haplotypic association with EH (empirical P ¼ 0.0072); GGG is a risk haplotype (P ¼ 0.043). The overall results support EMILIN1 as a candidate gene for human EH.
Introduction
Essential hypertension (EH), which affects about 25% of adults aged 30-69 years in Singapore, 1 has a multifactorial origin from an interaction of susceptibility genes with environmental influences. Many allelic risk factors have been validated in various populations, showing that the genetic risk is heterogeneous. A reduction in vascular compliance might contribute to the raised arterial blood pressure (BP) in EH. Studies of the pathogenesis of EH have therefore examined defects in vascular smooth muscle and endothelial cells, 2, 3 and also in the elastic extracellular matrix of blood vessels. 4 The association of EH with elastin haplo-insufficiency suggests that elastin defects in the elastic extracellular matrix are causative factors for hypertension. 5 The elastin microfibril interfacer-1 gene (EMILIN1), located on chromosome 2p23.3-p23.2 and containing eight exons spanning about 8.0 kb, regulates elastogenesis. 6 Its expressed protein stabilises elastin and related microfibrils. EMILIN1-deficient mice show abnormal anchorage of endothelial and smooth muscle cells to elastic lamellae in the aorta, 7 decreased vascular compliance and arterial hypertension. 8 The structure of the elastic extracellular matrix therefore affects vessel compliance and the BP. The roles of EMILIN1 protein are mediated through the inhibition of transforming growth factor-b; [9] [10] [11] the circulating levels of transforming growth factor-b1 mRNA and transforming growth factor-b1 protein are higher in hypertensive than in normotensive persons. 12 The inactivation of a single allele of transforming growth factor-b1 gene rescues EMILIN1 À/À animals from high blood pressure. 8, 13, 14 However, EMILIN1 has not been widely studied in human hypertension. A recent case-control study suggested that excluding control subjects with familial EH might improve the detection of association of gene variants with EH. 15 We therefore aimed to screen EMILIN1 for coding and non-coding singlenucleotide polymorphisms (SNPs), comparing unrelated hypertensive cases against normotensive control subjects both with and without familial hypertension.
We found significant genotypic association between three intronic SNPs of human EMILIN1 and the hypertensive phenotype, and provide evidence of linkage disequilibrium between EMILIN1 SNPs and hypertension.
Methods

Study population
The subjects were consecutively recruited in the National University of Singapore Investigation of Genetics of Hypertension study, 16 which was approved by the Ethics Committee (now the National Healthcare Group Institutional Review Board) of the National University Hospital, Singapore. Informed and written consent was obtained from each participant. We studied altogether 942 Chinese persons, consisting of 467 non-related hypertensive patients, 309 normotensive controls with a family history of hypertension in first-degree relatives (FHH) and 166 normotensive controls without FHH.
The 467 hypertensive cases comprised 442 patients with definite hypertension patients and 25 with borderline hypertension, as defined below.
Protocols and measurements
Patients were accepted as ethnic Chinese if all four of their grandparents were registered as 'of Chinese race' and spoke a Chinese dialect. We attempted to recruit normotensive controls aged above 55 years to limit the number who might later show hypertension.
Definite hypertension was defined as systolic and diastolic blood pressures X140 mm Hg and 90 mm Hg, respectively; or mean 24-h ambulatory BP X135/85 mm Hg. 16 The criteria corresponded to the threshold BP values for the topmost 5% of the BP distribution, in a survey of 4723 persons randomly recruited from the Singapore population. 17 Borderline hypertension was defined as either systolic BP of 135-139 mm Hg or diastolic BP of 85-89 mm Hg. Normotension was defined as a BP of 134/84 mm Hg or lower.
Systolic and diastolic BP values were taken as the mean of three measurements made at intervals of at least 5 min, recorded using the Omron HEM-705 CP digital BP monitor (Omron Corp., Tokyo, Japan), 16 matching the protocol for the British Genetics of Hypertension study. 18 The digital BP monitor had been validated by the British Hypertension Society. 18 We excluded individuals with body mass index X30; those who had received blood transfusion or organ transplantation; subjects with anaemia, chronic kidney disease, diabetes mellitus or cancer; and subjects who had experienced acute coronary or cerebrovascular events in the preceding 6 months. 16 Clinical chemistry measurements were made on fasting venous blood. Genomic DNA was extracted from the whole blood using the standard phenolchloroform method. 19 Variant screening and genotyping Eight putative SNPs of the EMILIN1 gene listed in dbSNP (Build 125, April 2006) (http://www. ncbi.nlm.nih) were screened for, using high-resolution double-stranded DNA (dsDNA) melt-curve analysis of introns 1 and 5, and exons 3 and 4. Amplicons from PCR were mixed with a 10 Â dsDNA binding saturating dye and LCGreen Plus, and scanned for sequence variation on a LightScanner (both from Idaho Technology, Salt Lake City, UT, USA). Melting of dsDNA was detected by a reduction in fluorescence when the sample was gradually heated.
Genotyping of the polymorphic variants was carried out using the melt-curve analysis of a single 3 0 -blocked unlabelled gene-specific oligonucleotide probe. 20, 21 Primer and probe sequences are given in Supplementary Table 1 on the journal's website. Asymmetrical PCR was completed and the singlestranded DNA (ssDNA) amplicon-probe duplex was melted in the presence of LCGreen Plus dye to detect changes in fluorescence. Both PCR-restriction fragment length polymorphism and direct sequencing on randomly selected samples verified the genotyped results.
Statistical analysis A sample size calculation had shown that, for a SNP with an allele frequency of 0.25 to attain a statistical significance level of Po0.05, we needed 436 subjects in each group if the allele's effect (odds ratio) was 1.5. 22 We determined allele and genotype frequencies by counting, and assessed Hardy-Weinberg equilibrium in each study group by means of Pearson's goodness-of-fit w 2 -test. We compared biometric variables between cases and controls using the w 2 -test for gender, smoking and alcohol intake, and one-way analysis of variance for the other continuous variables (SPSS for Windows, Rel.16.0.1.2007, SPSS Inc., Chicago, IL, USA).
As a preliminary evaluation had shown that the 442 'definite hypertension' and 25 'borderline hypertension' patients were indistinguishable, they were analyzed en bloc as hypertensive cases. Thus, we compared the differences in genotypic and allelic frequency between the controls and all 467 cases using the w 2 -test. The pattern of pair-wise linkage disequilibrium between the markers was expressed in terms of r 2 . Applying the case-control design and the recessive genetic model, the genetic association of each SNP with hypertension was individually tested by logistic regression with the following as covariates: gender, age, body mass index, serum fasting glucose, serum high density lipoprotein cholesterol and serum triglycerides. For logistic regression we used a web-based SNP analysis tool (Biostatistics and Bioinformatics Unit, Catalan Institute of Oncology, http://www.bioinfo.iconcologia.net/index.php?mod ule ¼ snpstats). 23 Using SPSS for Windows, we also evaluated the effect of EMILIN1 gene polymorphism on the BP of all the subjects by analysis of covariance, with adjustment for the above six covariates plus smoking and drinking. A P-value of o0.05 was considered statistically significant.
Haplotypes, consisting of rs2289360, rs2011616 and rs742455, were developed using the software programme PHASE version 2.1 (M Stephens, NJ Smith, P Donnelly, U of Washington, Seattle, WA, USA). 24 This software uses an algorithm to estimate haplotype frequencies and obtain the best haplotype configuration of each multi-locus genotype. Haplotype distributions were compared between hypertensive cases and the controls by the w 2 -test. We tested all the haplotypes for their overall association with hypertension using the Z clump statistical test (Medical statistics and Bioinformatics-Leiden University Medical Center, http://www.msbi.nl/dnn/Genetics/Tests forgeneticassociation/tabid/147/Default.aspx). 25 
Results
Subject characteristics
The demographic and clinical characteristics of all the 942 individuals (467 cases and 475 controls) are shown in Table 1 . The mean BP of the 467 hypertensive patients was 159/99 mm Hg, and that of the 475 normotensive control subjects and the 166 control subjects without FHH was 114/74 mm Hg (Table 1, Supplementary Table 2 ). The proportion of subjects with FHH was 88.1% in the 467 cases, 65.1% in all 475 control subjects and 0% in the 166 controls without FHH. On average, the hypertensive subjects had significantly higher body mass index and mean on-treatment BP than the control subjects taken together.
On average, the cases were slightly older than the controls (Table 1) , despite attempts to enrol older controls. However, mean age was similar in the cases and the controls without FHH (49.4 and 49.1 years, respectively (Supplementary Table 2) ). Average age at the onset of hypertension was 42.7±11.3 years in the cases. No significant demographic differences were observed between the two groups of controls, except that the controls with FHH were Table  2 ). None of the 942 unrelated individuals had fasting serum glucose X7.0 mmol l À1 . The cases had slightly higher serum glucose than the controls, and slightly lower serum HDL-cholesterol and higher triglycerides ( Table 1) . The rates of smoking and alcohol intake were similar in the cases and the controls (Table 1) .
Screening for genetic variants
Using high-resolution dsDNA melt-curve analysis of introns 1 and 5, and exons 3 and 4, we screened eight putative SNPs of the EMILIN1 gene then listed in dbSNP (Build 125, April 2006). Out of these eight SNPs, only three intronic SNPs, rs2289360, rs2011616 and rs742455, were observed and validated to be polymorphic in our Singaporean Chinese population. The three SNPs yielded different melt-curve profiles compared with reference sequenced samples, and were confirmed by PCRrestriction fragment length polymorphism and direct sequencing.
Genotyping of intronic SNPs
As the generic dsDNA melt-profiling method described above could not reliably distinguish between the three genotypes of a SNP, another type of melt-profiling assay was used to perform rapid and definitive genotyping for the three intronic SNPs. High-resolution melt-curve analysis of asymmetrically amplified ssDNA with an unlabelled allelespecific oligoprobe reliably distinguished between the three genotypes, and automated genotype calling occurred consistently.
Pearson's goodness-of-fit w 2 -test showed that the three intronic sites for cases and controls did not deviate significantly from Hardy-Weinberg expectations.
Genotypic and allelic frequencies of the three SNPs in the cases and controls are shown in Table 2 . The three intronic SNPs were in strong pair-wise linkage disequilibrium with one another (r 2 40.89, Figure 1 ). We observed significant differences in genotypic frequency at rs2289360 and rs7424556, but not at rs2011616, between hypertensive patients and the 166 control subjects who had no FHH (Table 2) . However, when 309 control subjects who had FHH were included in the comparison with Association of EMILIN1 gene with hypertension VMS Oh et al patients, the differences in frequency of both SNPs were no longer significant (Table 2 ). In regard to genotype frequency, the controls with FHH were not significantly different from the controls without FHH, or from the cases (Supplementary Table 3 ).
In the recessive genetic model, significant associations between the cases and controls without FHH were detected at rs2289360, rs2011616 and rs7424556 (P ¼ 0.010, P ¼ 0.038 and P ¼ 0.023, respectively) (Table 3) . A significant association between the cases and all the controls was found at rs2289360 only (P ¼ 0.049). The G alleles of rs2289360, rs2011616 and rs7424556 were the high-risk alleles for EH (Table 3) .
We made an analysis of covariance, adjusting for eight possible confounders, on the strongly associated marker rs2289360 to investigate the effect of the genotypes on BP (Table 4 ). There were significant differences in systolic BP and mean arterial pressure (adjusted P ¼ 0.048 and 0.042, respectively) between the three genotypes for rs2289360 in the pooled sample (n ¼ 633) of cases and controls without FHH. However, the absolute differences in BP between genotypes were small, and therefore unlikely to be physiologically important. We found no association of systolic and diastolic pressures, and mean arterial pressure, with both rs7424556 and rs2011616 (data not shown).
Haplotype analysis
Eight haplotypes were estimated from the three SNPs in the pooled sample of cases and controls without FHH. More than 90% of individuals had two common haplotypes (GGG or AAC). We observed a significant difference in haplotype frequency for the risk haplotype GGG (P ¼ 0.043). Another haplotype, AGG, was present in the healthy control population but not in the affected cases (Table 5) .
Using the Z clump statistic, we found a significant overall association between the haplotypes and hypertension (empirical P ¼ 0.0072).
Discussion
We detected a significant association between EH and three intronic SNPs of EMILIN1 (rs2289360, rs2011616 and rs7424556) in an association study in 942 non-diabetic ethnic Chinese patients and controls. Our study thus implicates EMILIN1 as a candidate gene for human EH. Though intronic SNPs do not directly alter cellular function, they might predispose patients to EH or influence their response to drug treatment.
The observation that FHH occurred more often in the 467 EH cases (88.1%) than in 475 normotensive control subjects (65.1%) is expected. We found a significant difference in the GG genotype frequency of each of the three intronic SNPs between the 467 cases and the 166 normotensive controls without FHH (Table 3) . Although the controls without FHH were relatively few, this result probably arose because phenotypic extremes were compared, namely selected controls (FHH in 0%) versus EH cases (FHH in 85.1%). The difference vanished when the 309 controls with FHH were included in the comparison (Table 3, Supplementary Table 3) , just as Shimodaira et al. had found. 15 Our observation thus confirms that excluding the controls with FHH increases the likelihood of detecting genetic differences. 
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Secondly, normotensive persons with FHH might be non-penetrant carriers of high-risk alleles. In physiological terms, healthy persons with hypertensive parents might have stiffer arteries 26 and higher 24-h ambulatory blood pressure 27 than those without FHH. Lastly, a few controls with FHH might later develop hypertension. The evidence therefore advocates enroling elderly normotensive controls without FHH in any case-control association study of hypertension.
The present study carefully phenotyped nonobese Chinese persons, whose fasting serum glucose was o7.0 mmol l À1 . The subjects therefore represent a sample of race-matched, non-obese and nondiabetic cases, and controls. The intention of the subject selection criteria, which preferred lean and euglycaemic subjects, 16 was both to decrease the effect of genes predisposing persons to obesity, diabetes and dyslipidaemia, and to increase the likelihood of detecting SNPs predisposing to hypertension. Significant but small differences in fasting serum glucose, high density lipoprotein cholesterol and triglycerides occurred between the cases and controls (Table 1) , because hypertensive persons tend to be heavier and to have lower serum high density lipoprotein cholesterol and higher triglycerides. 1, 16 The low rates of smoking and alcohol intake (Table 1) are consistent with those in the general population 1,17 and do not represent subject selection bias.
All of the three intronic SNPs identified in the present study (rs2289360, rs2011616 and rs7424556) are significantly associated with EH, only when the cases are compared with the controls without FHH (Table 3) . Assessing a larger number of controls without FHH might have yielded larger odds ratios. 
Abbreviations: EMILIN1, elastin microfibril interfacer1 gene; FHH, family history of hypertension in first-degree relatives; 95% CI, 95% confidence interval. In both the cases and the controls, the genotype distribution of the three polymorphisms was in Hardy-Weinberg equilibrium, which we assessed in each study group by means of Pearson's goodness-of-fit w 2 -test. In every instance, the recessive genetic model was used to compare common homozygotes with the pooled heterozygotes and rare homozygotes as the reference group. P-values were calculated by logistic regression, using a web-based SNP analysis tool, 23 with gender, age, BMI, fasting serum glucose, serum HDL-cholesterol, and serum triglycerides as covariates. (Table 1) .
When cases are compared with all the controls, only rs2289360 is associated with EH (Table 3) , suggesting that EH risk alleles in some controls with FHH decreased the odds ratios for the other SNPs.
Similarly, for the quantitative BP traits, only the SNP rs2289360 shows a significant positive association with systolic BP and mean arterial pressure in the pooled sample of cases and controls without FHH (Table 4 ). The SNP rs2289360 was omitted in a Japanese study by Shimodaira et al. 15 because of deviation from the Hardy-Weinberg equilibrium. Neither a study by Shen et al. in northern Han Chinese 28 nor a study by Shimodaira et al. 15 examined rs7424556. We identified rs7424556 after screening for genetic variants. Shen et al. 28 and Shimodaira et al. 15 might have missed rs7424556, because they selected their SNPs from public databases, such as those of the International HapMap Project and the NCBI.
The study by Shen et al. showed that northern Han Chinese aged 460 years with the A allele (AG/ AA genotype) of rs2011616 had increased risk for hypertension, but persons aged o50 years had a decreased risk. 28 This discrepant allelic effect on the BP is difficult to interpret. The present study in Singaporean Chinese subjects (mean age below 50 years) observed a similar association of EH with rs2011616 (Table 3) as found in northern Han Chinese subjects aged o50 years. 28 Similarly, the Japanese study by Shimodaira et al. in hypertensive patients and controls without FHH showed a genotypic association of EH with the G allele (AG/ GG genotype) of rs2011616. 15 The present study also detected an association of the G allele of rs2011616 with hypertension.
We did not identify one SNP that alone contributes significantly to the global association of the haplotypes of EMILIN1 (Table 5) . Shimodaira et al. 15 found EH linked to the GGT haplotype, just as the present study observed EH association with the common haplotype GGG (Table 5) . However, the two results are not comparable, because only rs2011616 was common to both studies. Shen et al. 28 did not report a haplotype analysis.
After evaluating all the above information, we believe that the positive associations of the three intronic SNPs of EMILIN1 with EH observed in the present study are valid and deserve further investigation.
In recent genome-wide association studies of hypertension using DNA microarray technology, the chips (for example, Affymetrix array 5.0, Affymetrix 6.0 and Illumina 1M 29-31 ) contained up to 1.2 million SNPs. The Illumina 1 M chip included the EMILIN1 SNPs rs2289360 and rs2011616, but not rs7424556. No 'hits' were reported in the three genome-wide association studies for the association of hypertension with rs2289360 and rs2011616, or with 30 other SNPs within 1000 bp of EMILIN1.
32-34
The modest associations that we found in the present study might not be sufficiently strong to be detected on a genome-wide scale.
In conclusion, our association study in EH cases and normotensive controls in a Singaporean Chinese population detected a significant association between hypertension and three intronic SNPs, rs2289360, rs2011616 and rs7424556, of EMILIN1. In case-control comparisons, selecting control subjects without FHH increases the likelihood of detecting association with hypertension. The work affirms EMILIN1 as a candidate gene for EH. To elucidate the role of EMILIN1 in the pathophysiology of hypertension, the gene should first be evaluated across the major ethnic groups both within and outside Asia.
What is known about this topic K Studies in animals suggest that EMILIN1, the gene encoding elastin microfibril interfacer-1 protein, contributes to the pathogenesis of hypertension, but evidence that EMILIN1 has a causative role in human hypertension is scanty. K Only two other studies in humans have reported evidence for association of SNPs in EMILIN1 with hypertension.
What this study adds K In this case-control study in Chinese persons, we found three polymorphisms in introns 1 and 5 of EMILIN1 that were in strong pair-wise linkage disequilibrium; three SNPs, rs2289360, rs201161 and rs7424556, which were associated with EH; and a significant association between the common risk haplotype GGG and EH. K The evidence supports EMILIN1 as a candidate gene for essential hypertension that requires further examination. K To increase test sensitivity in case-control studies, investigators should recruit elderly controls without hypertensive first-degree relatives. 
